Dolby Laboratories, Inc. — Q2 2016 Form 10-Q
Reporting period: Fiscal quarter ended April 1, 2016. The quarter comprised 14 weeks, compared with 13 weeks in the prior-year quarter; fiscal year-to-date (YTD) comprised 27 weeks versus 26 weeks. Dolby operates as one reporting segment and earns most revenue from licensing audio, imaging, and voice technologies.
Financial performance
| Metric | Q2 2016 | Q2 2015 | YTD 2016 | YTD 2015 |
|---|---|---|---|---|
| Revenue | $274.3 million | $272.0 million | $515.2 million | $506.2 million |
| Gross margin | $250.0 million (91.1%) | $246.8 million (90.8%) | $461.0 million (89.5%) | $461.6 million (91.2%) |
| Operating income | $82.3 million (30.0%) | $78.6 million (28.9%) | $121.5 million (23.6%) | $132.1 million (26.1%) |
| Net income attributable to Dolby | $67.4 million | $58.0 million | $98.3 million | $99.3 million |
| Diluted EPS | $0.66 | $0.56 | $0.97 | $0.95 |
| Operating cash flow | — | — | $156.9 million | $177.9 million |
Q2 revenue increased 0.9%; licensing revenue rose 2% to $249.3 million, while products fell 13% to $20.1 million and services fell 12% to $4.9 million. Q2 operating income and net income increased year over year. YTD revenue rose 1.8%, but operating income declined 8.0% and net income declined 1.0%; YTD diluted EPS increased to $0.97 from $0.95. The longer current-period duration affects comparability.
Liquidity and capital: At April 1, cash and cash equivalents were $521.2 million, short- and long-term investments totaled $372.4 million, and working capital was $587.8 million. Cash, cash equivalents, and investments totaled approximately $893.6 million. Total liabilities were $304.8 million; the filing reports no borrowings or debt balance. YTD share repurchases were $76.9 million and dividends paid were $24.2 million. Operating cash flow declined $21.1 million year over year; investing cash use was $71.4 million and financing cash use was $97.1 million.
Material changes and notable items
- Q2 licensing growth reflected higher broadcast and PC recoveries, partly offset by lower recoveries and unit volumes in some consumer electronics and gaming categories. YTD licensing was nearly flat.
- YTD product revenue increased 24%, primarily on cinema warranty revenue and higher volumes of 3D, Atmos, and digital cinema products. Q2 product revenue declined on lower cinema product units and average selling prices.
- YTD cost of licensing increased 82%, partly reflecting amortization of acquired intangible assets. In September 2015, Dolby acquired a patent portfolio for $105 million, recorded as acquired patents and technology.
- Q2 tax expense was $16.3 million and the effective tax rate fell to 19% from 27%. A $5.7 million tax benefit followed settlement of a California tax examination; increased federal R&D credits also contributed. YTD effective tax rate was 20%, versus 25%.
- Dolby recorded $1.3 million of restructuring charges for a January 2016 reorganization affecting approximately 30 employees; no related accrual remained at quarter-end.
Outlook, commentary, and risks
Management stated that available cash, investments, and operating cash flows were expected to meet anticipated cash requirements for at least the next 12 months. The filing provides no quantified revenue, earnings, or margin guidance. Management highlighted expansion opportunities in Dolby Vision, Dolby Cinema, Dolby Atmos, and Dolby Voice, while noting that adoption, deployment, and monetization remain uncertain. More than 200 Dolby Cinema screens had been committed, with just over 20 launched; Dolby Vision TV and streaming-content adoption was expanding.
Key risks include reliance on licensees’ product shipments and royalty reporting; declining PC and optical-disc markets; competition, pricing pressure, and technology substitution; patent expiration and intellectual-property enforcement challenges; uncertain adoption of new growth initiatives; international, currency, and tax exposures; and customer, supplier, and execution risks. Approximately 64% of cash, cash equivalents, and investments were held by foreign subsidiaries and could incur tax if repatriated. Contractual commitments totaled $249.2 million, including $134.0 million for naming rights and $75.8 million for operating leases. Ongoing legal matters were not expected by management to have a material adverse effect, though outcomes are uncertain.
Important facts for investors to verify
- Whether licensing growth and recurring recoveries can continue, and how much Q2 performance reflects the extra fiscal week.
- Drivers of the YTD decline in operating income and gross margin, including licensing amortization and investment in sales and marketing.
- Whether new Dolby Vision, Dolby Cinema, and Dolby Voice deployments convert into sustained revenue and returns.
- Cash-flow trends, planned capital spending, repurchases and dividends, and the implications of foreign-held funds.
- Potential effects of patent expirations, licensee reporting or disputes, tax contingencies, and other legal or regulatory matters.